Seed Funding: How Much Did They Raise & Key Investors

How Much Did Seed Raise?
Funding & Key Investors

Seed, a prominent player in the consumer biotechnology sector, has successfully secured a major strategic investment, bringing its total capital accumulation to $40M. This latest infusion of $40M underscores the company's robust growth trajectory and its increasing influence within the competitive landscape of microbiome-based health solutions. By leveraging this significant financial backing, Seed continues to solidify its market position as a leader in the development and manufacturing of high-efficacy probiotic bacteria supplements.

The recent financing round, finalized in April 2021, represents a pivotal moment for the Venice-based firm. As the company transitions through its current lifecycle stage, this capital injection serves as a catalyst for scaling operations and expanding its reach within the global wellness market. The participation of high-profile institutional investors highlights the industry's confidence in Seed's scientific approach and its potential to redefine standards in the probiotic supplement category.

What is Seed?

Seed

Manufacturing

Health & Nutrition Products

Retail

Seed operates at the intersection of consumer packaged goods and advanced biotechnology. Headquartered in Venice, California, the company specializes in the research, development, and commercialization of probiotic supplements designed to support human health through the microbiome. Unlike traditional supplement providers, Seed emphasizes a rigorous, science-first methodology, positioning itself as a premium brand that bridges the gap between clinical research and consumer accessibility. Its market position is characterized by a commitment to transparency, sustainability, and the application of cutting-edge microbial science to address diverse health needs, effectively disrupting the conventional wellness industry.

How much funding has Seed raised?

Seed has raised a total of $40M across 1 funding round:

2021

Series A

$40M

Series A (2021): $40M with participation from The Craftory, 8VC, Founders Fund, GISEV, and Artis Ventures Management Iii

Key Investors in Seed

The Craftory

A consumer venture capital fund based in London and San Francisco that focuses on investing in consumer brands with a positive social impact and sustainable business models.

8VC

A leading technology investment firm managing billions in capital, specializing in smart enterprise platforms across sectors including Bio-IT, healthcare, and logistics.

Founders Fund

A prominent venture capital firm known for backing transformative companies across all stages, with a history of supporting industry-defining organizations like SpaceX and Stripe.

What's next for Seed?

With the successful closure of this major enterprise-level funding, Seed is well-positioned to accelerate its strategic initiatives. The company is expected to focus on scaling its manufacturing capabilities to meet rising consumer demand while simultaneously investing in further clinical research to validate its product efficacy. Furthermore, the infusion of capital will likely support the expansion of its distribution channels and the development of new, data-driven health solutions. As Seed continues to navigate the complexities of the biotech landscape, the strategic guidance provided by its diverse investor base will be instrumental in maintaining its competitive edge and fostering long-term, sustainable growth in the global health and wellness sector.

See full Seed company page

See More Financial Insights